Publications by authors named "Chen-Yang Ye"

Claim this Profile
A
Anlotinib plus sintilimab as first-line treatment for patients with advanced colorectal cancer (APICAL-CRC): an open-label, single-arm, phase II trial.
Zhan Wang, Bao-Dong Qin, Chen-Yang Ye, Miao-Miao Wang, Ling-Yan Yuan

Signal Transduct Target Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The sub-arc mantle has remained oxidized since the Neoproterozoic oxygenation event.
Chun-Tao Liu, Chen-Yang Ye, Qun-Ke Xia, J ZhangZhou

Nat Commun· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remote Spin-Center Shift Enables Activation of Distal Benzylic C─O and C─N Bonds.
Li-Wen Hui, Yee Lin Phang, Chen-Yang Ye, Jin-Yu Lai, Feng-Lian Zhang

Angew Chem Int Ed Engl· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anlotinib plus toripalimab as a first-line treatment in patients with advanced gastric cancer and performance status 2: the phase II APICAL-GC trial.
Ke Liu, Bao-Dong Qin, Shi-Qi Chen, Xue Zhong, Xiao-Peng Duan, Chen-Yang Ye

Nat Commun· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An active representation learning method for reaction yield prediction with small-scale data.
Peng-Xiang Hua, Zhen Huang, Zhe-Yuan Xu, Qiang Zhao, Chen-Yang Ye

Commun Chem· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Membrane-associated RING-CH protein (MARCH8) is a novel glycolysis repressor targeted by miR-32 in colorectal cancer.
Zhan Wang, Miao-Miao Wang, Yan Geng, Chen-Yang Ye, Yuan-Sheng Zang

J Transl Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cetuximab and vemurafenib plus FOLFIRI (5-fluorouracil/leucovorin/irinotecan) for BRAF V600E-mutated advanced colorectal cancer (IMPROVEMENT): An open-label, single-arm, phase II trial.
Zhan Wang, Bao-Dong Qin, Chen-Yang Ye, Miao-Miao Wang, Ling-Yan Yuan

Eur J Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durable Clinical Response to ALK Tyrosine Kinase Inhibitors in Epithelioid Inflammatory Myofibroblastic Sarcoma Harboring Rearrangement: A Case Report.
Zhan Wang, Yan Geng, Ling-Yan Yuan, Miao-Miao Wang, Chen-Yang Ye

Front Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Dynamic ctDNA Monitoring During Combination Therapies of BRAF V600E-Mutated Metastatic Colorectal Cancer: A Case Report.
Zhan Wang, Chen-Yang Ye, Wen-Li Zhou, Miao-Miao Wang, Wei-Ping Dai

Onco Targets Ther· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A meta-analysis of efficacy and safety of S-1 monotherapy or combination therapy as first-line treatment in metastatic colorectal cancer.
Zhan Wang, Miao-Miao Wang, Wen-Li Zhou, Chen-Yang Ye, Wei-Ping Dai

Int J Colorectal Dis· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Mobility Group Box 1 (HMGB1) and Autophagy in Acute Lung Injury (ALI): A Review.
Lihua Qu, Chao Chen, YangYe Chen, Yi Li, Fang Tang

Med Sci Monit· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diffuse alveolar hemorrhage after erlotinib combined with concurrent chemoradiotherapy in a patient with esophageal carcinoma.
Chuan-Hua Zhao, Rong-Rui Liu, Li Lin, Jian-Zhi Liu, Fei-Jiao Ge, Chen-Yang Ye

Int J Clin Exp Med· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis